- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Study Raises Concerns About Accuracy of Insulin Dosing Apps
The study, conducted by the Global eHealth Unit at the Imperial College London, has found that the majority of insulin dosing apps are unreliable and put patients at risk of getting incorrect doses of insulin. Does this demand an FDA oversight of the apps?
A recent study led by the Global eHealth Unit at the Imperial College London has found that the majority of insulin dosing apps are unreliable and put patients at risk of getting incorrect doses of insulin.
For patients on insulin, meal-time dosing of short-acting insulin is a challenging task. There are a lot of factors that go in to deciding how much insulin to administer—anticipated carbohydrate intake, premeal blood sugar, planned activities afterwards, and more. A simple calculator app to help out seems like a no-brainer. And there are a lot of apps out there that claim to do that.
Huckvale and colleagues found 46 insulin dose calculator apps in the app stores. When they evaluated these apps, they found some pretty concerning patterns.
Read the complete article on MedpageToday: http://bit.ly/1PIpbOI
Liquid Biopsy Whole-Genome Sequencing Optimizes MRD Detection in DLBCL
April 13th 2024Using the newly created MAESTRO-Pool tool, whole genome sequencing revealed DNA that could be used to more effectively detect minimum residual disease (MRD) in patients who have diffuse large B-cell lymphoma (DLBCL).
Read More
